Detalhe da pesquisa
1.
Tuberculosis incidence in foreign-born people residing in European countries in 2020.
Euro Surveill;
28(42)2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37855907
2.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Eur Respir J;
54(6)2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31601711
3.
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
Eur Respir J;
59(5)2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35589114
4.
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
Clin Infect Dis;
62(4): 418-430, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26508515
5.
Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.
Emerg Infect Dis;
22(3): 482-90, 2016 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26889608
6.
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
Clin Infect Dis;
59(8): 1049-63, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25057101
7.
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
Eur Respir J;
53(1)2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30606765
8.
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.
Eur Respir J;
44(1): 23-63, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24659544
9.
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.
Eur Respir J;
51(3)2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29419439
10.
Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.
Eur Respir J;
50(5)2017 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29122917
11.
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lancet Respir Med;
8(4): 383-394, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32192585
12.
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.
BMJ Open;
10(6): e035350, 2020 06 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32554740
13.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.
Int J Infect Dis;
83: 72-76, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30953827
14.
Management of patients with multi-drug resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz
| ID: arc-10621